Skip to content
10-K/A

Annual Report

Oncologix Tech Inc.

0001471242-14-000418

← back to feed
Filed
Dec 15, 2014 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2014 · Nov 19, 2014 146.37M sh
Shares Outstanding FY 2014 · Aug 31, 2014 127.55M sh
Capex FY 2014 · Aug 31, 2014 −$878
Operating Cash Flow FY 2014 · Aug 31, 2014 −$629.94K
Short Term Debt FY 2014 · Aug 31, 2014 $82.53K
Cash And Equivalents FY 2014 · Aug 31, 2014 $17.5K
Stockholders Equity FY 2014 · Aug 31, 2014 −$664.72K
Current Liabilities FY 2014 · Aug 31, 2014 $2.4M
Total Liabilities FY 2014 · Aug 31, 2014 $2.8M
Current Assets FY 2014 · Aug 31, 2014 $274.63K
Total Assets FY 2014 · Aug 31, 2014 $2.14M
Sga Expense FY 2014 · Aug 31, 2014 $1.13M
Rd Expense FY 2014 · Aug 31, 2014 $30K
Net Income FY 2014 · Aug 31, 2014 −$1.31M
Operating Income FY 2014 · Aug 31, 2014 −$571.84K
Gross Profit FY 2014 · Aug 31, 2014 $614.41K
Cost Of Revenue FY 2014 · Aug 31, 2014 $3.06M
Revenue FY 2014 · Aug 31, 2014 $3.68M